ID

42640

Descripción

A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00744991

Link

https://clinicaltrials.gov/show/NCT00744991

Palabras clave

Versiones (2)
  1. 5/2/18 5/2/18 -
  2. 17/9/21 17/9/21 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

Inglés

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed mycosis fungoides or sezary syndrome
Descripción

Mycosis Fungoides | Sezary Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026948
UMLS CUI [2]
C0036920
stage ib to ivb disease at screening
Descripción

Disease Ann Arbor lymphoma staging system

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0432516
recurrent or refractory disease after at least 1 prior systemic therapy
Descripción

Recurrent disease | Refractory Disease | Status post Systemic therapy Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C1514815
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1515119
UMLS CUI [3,3]
C1265611
have adequate organ function defined as:
Descripción

Organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
at least 30 days must have passed since other treatment for ctcl.
Descripción

Therapeutic procedure Cutaneous T-Cell Lymphoma | Requirement Elapsed Time

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0079773
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C2826303
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
receiving concurrent treatment for ctcl
Descripción

Therapeutic procedure Cutaneous T-Cell Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0079773
unable to swallow tablets
Descripción

Lacking Able to swallow Tablets

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0039225
receiving high potency oral or topical steroids. low potency oral steroid may be permitted in patients who have been on a stable dose for at least 4 weeks prior to screening. oral or topical antihistamine is allowed.
Descripción

Steroids Oral High Potency | Topical steroids High Potency | Antihistamines Oral allowed | Topical antihistamine allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1656349
UMLS CUI [2,1]
C2064827
UMLS CUI [2,2]
C1656349
UMLS CUI [3,1]
C0019590
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0683607
UMLS CUI [4,1]
C0357949
UMLS CUI [4,2]
C0683607
unable to discontinue use of carbamazepine, phenobarbital, or phenytoin
Descripción

Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006949
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0031412
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0031507
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
have a serious concomitant systemic disorder or hiv
Descripción

HIV Infection Systemic Serious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0205404
have a serious cardiac condition such as myocardial infarction within past 6 months, angina, or heart disease as defined by the new york heart association (nyha) class iii or iv
Descripción

Cardiac problem Serious | Myocardial Infarction | Angina Pectoris | Heart Disease New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262402
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0002962
UMLS CUI [4,1]
C0018799
UMLS CUI [4,2]
C1275491
have ecg abnormalities,
Descripción

ECG abnormality

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0522055
are pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Mycosis Fungoides | Sezary Syndrome
Item
histologically confirmed mycosis fungoides or sezary syndrome
boolean
C0026948 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
Disease Ann Arbor lymphoma staging system
Item
stage ib to ivb disease at screening
boolean
C0012634 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Recurrent disease | Refractory Disease | Status post Systemic therapy Quantity
Item
recurrent or refractory disease after at least 1 prior systemic therapy
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C1515119 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Organ function
Item
have adequate organ function defined as:
boolean
C0678852 (UMLS CUI [1])
Therapeutic procedure Cutaneous T-Cell Lymphoma | Requirement Elapsed Time
Item
at least 30 days must have passed since other treatment for ctcl.
boolean
C0087111 (UMLS CUI [1,1])
C0079773 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C2826303 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Cutaneous T-Cell Lymphoma
Item
receiving concurrent treatment for ctcl
boolean
C0087111 (UMLS CUI [1,1])
C0079773 (UMLS CUI [1,2])
Lacking Able to swallow Tablets
Item
unable to swallow tablets
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Steroids Oral High Potency | Topical steroids High Potency | Antihistamines Oral allowed | Topical antihistamine allowed
Item
receiving high potency oral or topical steroids. low potency oral steroid may be permitted in patients who have been on a stable dose for at least 4 weeks prior to screening. oral or topical antihistamine is allowed.
boolean
C0038317 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1656349 (UMLS CUI [1,3])
C2064827 (UMLS CUI [2,1])
C1656349 (UMLS CUI [2,2])
C0019590 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0683607 (UMLS CUI [3,3])
C0357949 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable
Item
unable to discontinue use of carbamazepine, phenobarbital, or phenytoin
boolean
C0006949 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0031412 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0031507 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
HIV Infection Systemic Serious
Item
have a serious concomitant systemic disorder or hiv
boolean
C0019693 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
Cardiac problem Serious | Myocardial Infarction | Angina Pectoris | Heart Disease New York Heart Association Classification
Item
have a serious cardiac condition such as myocardial infarction within past 6 months, angina, or heart disease as defined by the new york heart association (nyha) class iii or iv
boolean
C0262402 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2])
C0002962 (UMLS CUI [3])
C0018799 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
ECG abnormality
Item
have ecg abnormalities,
boolean
C0522055 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial